» Articles » PMID: 7677761

Molecular Cloning of a Putative Ca(2+)-sensing Receptor CDNA from Human Kidney

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1995 Sep 14
PMID 7677761
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

A cDNA that encodes a putative Ca(2+)-sensing receptor (HuKCaSR) was cloned from human kidney with the use of the polymerase chain reaction. The predicted HuKCaSR protein consists of 1078 amino acids and shares 93.1 and 93.8% overall identity with the bovine parathyroid Ca(2+)-sensing receptor (BoPCaR1) and rat kidney Ca(2+)-sensing receptor (RaKCaR), respectively, with least similarity in the carboxyl-terminal regions. The HuKCaSR gene was mapped by fluorescence in situ hybridization to chromosome 3q21, at which region the gene responsible for familial hypocalciuric hypercalcemia has previously been localized by genetic linkage analyses. RNA blot analysis revealed HuKCaSR mRNA in human kidney, but not in brain, lung, liver, heart, skeletal muscle, or placenta.

Citing Articles

Calcium and vitamin D substitution for hypoparathyroidism after thyroidectomy - how is it continued after discharge from hospital?.

Staubitz-Vernazza J, Lederer A, Bouzakri N, Lozan O, Wild F, Musholt T Langenbecks Arch Surg. 2024; 409(1):373.

PMID: 39636417 PMC: 11621183. DOI: 10.1007/s00423-024-03556-w.


Sequencing the CaSR locus in Pakistani stone formers reveals a novel loss-of-function variant atypically associated with nephrolithiasis.

Ullah I, Ottlewski I, Shehzad W, Riaz A, Ijaz S, Tufail A BMC Med Genomics. 2021; 14(1):266.

PMID: 34772415 PMC: 8588693. DOI: 10.1186/s12920-021-01116-5.


Old and New Drugs for the Management of Bone Disorders in CKD.

Komaba H, Ketteler M, Cunningham J, Fukagawa M Calcif Tissue Int. 2021; 108(4):486-495.

PMID: 33386480 DOI: 10.1007/s00223-020-00788-y.


Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice.

Juhlin C, Erickson L Endocr Pathol. 2020; 32(1):17-34.

PMID: 33269427 PMC: 7960610. DOI: 10.1007/s12022-020-09656-9.


The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases.

Das S, Clezardin P, Kamel S, Brazier M, Mentaverri R Front Oncol. 2020; 10:69.

PMID: 32117726 PMC: 7013091. DOI: 10.3389/fonc.2020.00069.